NHS Logo

Pharmaceutical Nanobiotechnology for Targeted Therapy (Record no. 101190)

MARC details
000 -LEADER
fixed length control field 05153nam a22005175i 4500
001 - CONTROL NUMBER
control field 978-3-031-12658-1
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729134156.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221018s2022 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783031126581
-- 978-3-031-12658-1
072 #7 - SUBJECT CATEGORY CODE
Subject category code TCB
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI010000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code TCB
Source thema
245 10 - TITLE STATEMENT
Title Pharmaceutical Nanobiotechnology for Targeted Therapy
250 ## - EDITION
Edition statement 1st ed. 2022.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Physical description XIV, 639 p. 127 illus., 102 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Nanotechnology in the Life Sciences,
International Standard Serial Number 2523-8035
505 0# - CONTENTS
Contents Preface -- Chapter. 1. Outer Membrane Vesicles (OMVs) as a Platform for Vaccination and Targeted Drug Delivery -- Chapter. 2. CRISPR/Cas9 Nano-Delivery Approaches for Targeted Gene Therapy -- Chapter. 3. Lipoplexes and Polyplexes for Targeted Gene Delivery -- Chapter. 4. Aptamer-Based Targeted Drug Delivery Systems -- Chapter. 5. Artificial Exosomes as Targeted Drug Delivery Systems -- Chapter. 6. Nanoarchaeosomes in drug delivery -- Chapter. 7. Bioengineered Metallic Nanomaterials for Nanoscale Drug Delivery Systems -- Chapter. 8. Nanobody-Based Delivery Systems for Diagnosis and Therapeutic Applications -- Chapter. 9. Phytosomes Used for Herbal Drug Delivery -- Chapter. 10. Porphysomes and porphyrin-based nanomaterials for drug delivery system -- Chapter. 11. Ethosomes for Dermal and Transdermal Drug Delivery Systems -- Chapter. 12. Liposomes and Niosomes for Targeted Drugs and Gene Delivery Systems -- Chapter. 13. Dendrimers as Targeted Systems for Selective Gene and Drug delivery -- Chapter. 14. Polymersomes for Targeted Drug and Gene Delivery Systems -- Chapter. 15. Quantum-Dot-Based Nanomaterials for Diagnostic and Therapeutic applications -- Chapter. 16. Carbon-based Nanomaterials for Targeted Drug and Gene Delivery Systems -- Chapter. 17. Hybrid Multifunctional Nanomaterials for Diagnostic and Therapeutic Applications -- Chapter. 18. Polymeric Micelles for Targeted Drug Delivery Systems -- Chapter. 19. Polymeric Nanoparticles for Targeted Drug and Gene Delivery Systems -- Chapter. 20. Magnetic Nanoparticles for Diagnostic and Therapeutic Applications.
520 ## - ABSTRACT
Abstract The field of nanotechnology for targeted therapy initiated more than decade ago has grown fast and interest is increasing. Given the importance of the field for targeted drug and gene delivery systems, there are a large number of laboratory investigations today researching nanobiomaterials for diagnostic and therapeutic applications. Because of the ability of scientists to load nanoparticles with any agent, interest continues to grow and technology in this arena is rapidly evolving. These emerging nanobiomaterials-based medicines can overcome the disadvantages of traditional medicines by target-oriented and site-specific delivery of precise medicines (immunotherapeutic agents, chemotherapeutic agents, diagnostic agents, and so on). Pharmaceutical Nanobiotechnology for Targeted Therapy presents an updated overview of recent advancements in the field of pharmaceutical nanobiotechnology and nano-based drug and gene delivery systems. This comprehensive knowledge will allow researchers to discover innovative nanobiomaterials for targeted therapeutics. The chapters deal with various emerging nanobiomaterials for targeted therapeutic delivery systems and the writing is in a style that is easily disseminated and in a manner that can be readily adopted as sources for new and further studies. This book should be useful for researchers and professionals from academia and industry working in the field of nanotechnology, nanobiotechnology, as well as in the field of pharmaceutical nanotechnology. It should also be useful to those interested in a range of disciplines from material science, chemistry, molecular biology, polymer chemistry, and many more interdisciplinary areas.
650 #0 - SUBJECT HEADINGS
Subject term Biotechnology.
9 (RLIN) 5393
650 #0 - SUBJECT HEADINGS
Subject term Biology
General subdivision Technique.
650 #0 - SUBJECT HEADINGS
Subject term Molecular biology.
9 (RLIN) 7018
650 #0 - SUBJECT HEADINGS
Subject term Nanotechnology.
650 14 - SUBJECT HEADINGS
Subject term Biotechnology.
9 (RLIN) 5393
650 24 - SUBJECT HEADINGS
Subject term Biological Techniques.
650 24 - SUBJECT HEADINGS
Subject term Molecular Biology.
9 (RLIN) 7018
650 24 - SUBJECT HEADINGS
Subject term Nanotechnology.
700 1# - ADDED PERSONAL NAME
Added personal author Barabadi, Hamed.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Mostafavi, Ebrahim.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Saravanan, Muthupandian.
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Nanotechnology in the Life Sciences,
International Standard Serial Number 2523-8035
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SBL
912 ## -
-- ZDB-2-SXB
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer BiomedLifeSc   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-3-031-12658-1 02/05/2024 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions